GE HealthCare Technologies Inc. $GEHC Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 173,486 shares of the company’s stock after selling 91,088 shares during the period. Commonwealth Equity Services LLC’s holdings in GE HealthCare Technologies were worth $13,029,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of GEHC. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of GE HealthCare Technologies by 4.2% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 159,882 shares of the company’s stock valued at $11,842,000 after buying an additional 6,479 shares in the last quarter. Wedge Capital Management L L P NC purchased a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $26,859,000. Lineweaver Wealth Advisors LLC acquired a new stake in GE HealthCare Technologies in the second quarter valued at approximately $592,000. Valicenti Advisory Services Inc. grew its position in GE HealthCare Technologies by 22.6% in the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock valued at $5,115,000 after acquiring an additional 12,550 shares in the last quarter. Finally, National Bank of Canada FI raised its stake in shares of GE HealthCare Technologies by 133.3% during the second quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock valued at $66,640,000 after purchasing an additional 514,007 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.0%

Shares of NASDAQ GEHC opened at $87.28 on Friday. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The stock’s 50 day moving average price is $80.30 and its two-hundred day moving average price is $76.70. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The stock has a market capitalization of $39.76 billion, a P/E ratio of 18.03, a PEG ratio of 3.39 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is presently 2.89%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. The Goldman Sachs Group reaffirmed a “buy” rating and set a $98.00 price target on shares of GE HealthCare Technologies in a report on Friday. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. BTIG Research reaffirmed a “buy” rating and set a $87.00 target price on shares of GE HealthCare Technologies in a research report on Friday, November 21st. Stifel Nicolaus increased their price target on GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Evercore ISI restated an “outperform” rating and set a $95.00 price objective on shares of GE HealthCare Technologies in a report on Monday, January 5th. Seven investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $89.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.